UVC irradiation for pathogen reduction of platelet concentrates and plasma

Transfusion Medicine and Hemotherapy

Volumn 38, Issue 1, 2011, Pages 43-54

  Seltsam, Axel ^a   Müller, Thomas H ^a  

^a Institute Springe   (Germany)

Author keywords

Blood units; Pathogen inactivation; Plasma; Platelet concentrates; UVC

Indexed keywords

DIMER; NUCLEIC ACID; PROTEIN; PROTEOME; THROMBOCYTE CONCENTRATE;

ARTICLE; BACILLUS CEREUS; BLOOD BANK; BLOOD CLOTTING; BLOOD COMPONENT; BLOOD TRANSFUSION; CHEMICAL STRUCTURE; CLINICAL EVALUATION; CLOSTRIDIUM PERFRINGENS; CONTAMINATION; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; LEUKOCYTE; LIGHT ABSORPTION; MICROBIOLOGICAL PHENOMENA AND FUNCTIONS; NONHUMAN; PARASITE; PATHOGEN REDUCTION; PLASMA; PROPIONIBACTERIUM ACNES; PSEUDOMONAS AERUGINOSA; RISK REDUCTION; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TECHNOLOGY; THROMBOCYTE FUNCTION; ULTRAVIOLET C RADIATION; ULTRAVIOLET IRRADIATION; VIRUS INACTIVATION;

EID: 79851495960     PISSN: 16603796     EISSN: None     Source Type: Journal    
DOI: 10.1159/000323845     Document Type: Article

References (61)

1. Dodd RY: Current risk for transfusion transmitted infections. Curr Opin Hematol 2007;14:671-676. (Pubitemid 47494085)
2. Webert KE, Cserti CM, Hannon J, Lin Y, Pavenski K, Pendergrast JM, Blajchman MA: Proceedings of a consensus conference: pathogen inactivation-making decisions about new technologies. Transfus Med Rev 2008;22:1-34. (Pubitemid 350193270)
3. Teitel JM: Viral safety of haemophilia treatment products. Ann Med 2000;32:485-492.
4. Mohr H, Gravemann U, Bayer A, Muller TH: Sterilization of platelet concentrates at produc-tion scale by irradiation with short-wave ultraviolet light. Transfusion 2009;49:1956-1963.
5. Mohr H, Gravemann U, Müller TH: Inactivation of pathogens in single units of therapeutic fresh plasma by irradiation with ultraviolet light. Transfusion 2009;49:2144-2151.
6. Mohr H, Steil L, Gravemann U, Thiele T, Hammer E, Greinacher A, Müller TH, Volker U: A novel approach to pathogen reduction in platelet con-centrates using short-wave ultraviolet light. Transfusion 2009;49:2612-2624.
7. Calkins J, Wheeler JS, Keller CI, Colley E, Hazle JD: Comparative ultraviolet action spectra (254-320 nm) of five 'wild-type' eukaryotic microorganisms and Escherichia coli. Radiat Res 1988;114:307-318.
8. Kallenbach NR, Cornelius PA, Negus D, Mont-gomerie D, Englander S: Inactivation of viruses by ultraviolet light. Curr Stud Hematol Blood Trans-fus 1989:70-82. (Pubitemid 19003846)
9. Caillet-Fauquet P, Di Giambattista M, Draps ML, Sandras F, Branckaert T, de Launoit Y, Laub R: Continuous-flow UVC irradiation: a new, effective, protein activity-preserving system for inactivating bacteria and viruses, including erythrovirus B19. J Virol Methods 2004;118:131-139. (Pubitemid 38479742)
10. Chin S, Williams B, Gottlieb P, Margolis-Nunno H, Ben-Hur E, Hamman J, Jin R, Dubovi E, Horow-itz B: Virucidal short wavelength ultraviolet light treatment of plasma and factor VIII concentrate: protection of proteins by antioxidants. Blood 1995; 86:4331-4336.
11. Hart H, Reid K, Hart W: Inactivation of viruses during ultraviolet light treatment of human intra-venous immunoglobulin and albumin. Vox Sang 1993;64:82-88. (Pubitemid 23079200)
12. Terpstra FG, van't Wout AB, Schuitemaker H, van Engelenburg FA, Dekkers DW, Verhaar R, de Korte D, Verhoeven AJ: Potential and limitation of UVC irradiation for the inactivation of patho-gens in platelet concentrates. Transfusion 2008;48: 304-313.
13. Cadet J, Sage E, Douki T: Ultraviolet radiation-mediated damage to cellular DNA. Mutat Res 2005;571:3-17. (Pubitemid 40313428)
14. Sinha RP, Hader DP: UV-induced DNA damage and repair: a review. Photochem Photobiol Sci 2002;1:225-236. (Pubitemid 37069733)
15. Douki T, Laporte G, Cadet J: Inter-strand photo-products are produced in high yield within A-DNA exposed to UVC radiation. Nucleic Acids Res 2003;31:3134-3142. (Pubitemid 37441773)
16. Rodrigo G, Roumagnac S, Wold MS, Salles B, Cal-sou P: DNA replication but not nucleotide excision repair is required for UVC-induced replication protein A phosphorylation in mammalian cells. Mol Cell Biol 2000;20:2696-2705. (Pubitemid 30183488)
17. Pohler P, Lehmann J, Veneruso V, Lambrecht B, Mohr H, Mueller TH, Seltsam A: THERAFLEX UV-platelets: no evidence for intolerance and an-tibody formation in dogs during a 10-week safety pharmacology study. Transfus Med Hemother 2009;36(suppl 1):47.
18. Bashir S, Thomas S, Cardigan R, Struff WG, Tolksdorf F, Williamson LM: Pathogen inactiva-tion of platelets using UVC light. Transfus Med 2010;20(suppl 1):8.
19. Lin L, Cook DN, Wiesehahn GP, Alfonso R, Behr-man B, Cimino GD, Corten L, Damonte PB, Dike-man R, Dupuis K, Fang YM, Hanson CV, Hearst JE, Lin CY, Londe HF, Metchette K, Nerio AT, Pu JT, Reames AA, Rheinschmidt M, Tessman J, Isaacs ST, Wollowitz S, Corash L: Photochemical inactiva-tion of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ul-traviolet light. Transfusion 1997;37:423-435. (Pubitemid 27193557)
20. Goodrich RP: The use of riboflavin for the inacti-vation of pathogens in blood products. Vox Sang 2000;78(suppl 2):211-215.
21. Reddy HL, Dayan AD, Cavagnaro J, Gad S, Li J, Goodrich RP: Toxicity testing of a novel ribofla-vin-based technology for pathogen reduction and white blood cell inactivation. Transfus Med Rev 2008;22:133-153. (Pubitemid 351384824)
22. Ciaravino V, McCullough T, Cimino G, Sullivan T: Preclinical safety profile of plasma prepared using the INTERCEPT Blood System. Vox Sang 2003; 85:171-182. (Pubitemid 37247800)
23. Slichter SJ, Deeg HJ, Kennedy MS: Prevention of platelet alloimmunization in dogs with systemic cy-closporine and by UV-irradiation or cyclosporine-loading of donor platelets. Blood 1987;69:414-418. (Pubitemid 17022007)
24. Slichter SJ, Fish D, Abrams VK, Gaur L, Nelson K, Bolgiano D: Evaluation of different methods of leukoreduction of donor platelets to prevent alloimmune platelet refractoriness and induce tol-erance in a canine transfusion model. Blood 2005; 105:847-854. (Pubitemid 40070774)
25. Singh Y, Sawyer LS, Pinkoski LS, Dupuis KW, Hsu JC, Lin L, Corash L: Photochemical treatment of plasma with amotosalen and long-wavelength ultra-violet light inactivates pathogens while retaining co-agulation function. Transfusion 2006;46:1168-1177. (Pubitemid 44139491)
26. Goodrich RP, Edrich RA, Li J, Seghatchian J: The Mirasol™ PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends. Transfus Apher Sci 2006;35:5-17. (Pubitemid 44354317)
27. Solheim BG, Seghatchian J: Update on pathogen reduction technology for therapeutic plasma: an overview. Transfus Apher Sci 2006;35:83-90. (Pubitemid 44354323)
28. Garwood M, Cardigan RA, Drummond O, Horn-sey VS, Turner CP, Young D, Williamson LM, Prowse CV: The effect of methylene blue pho-toinactivation and methylene blue removal on the quality of fresh-frozen plasma. Transfusion 2003; 43:1238-1247. (Pubitemid 37082684)
29. van Rhenen DJ, Vermeij J, Mayaudon V, Hind C, Lin L, Corash L: Functional characteristics of S-59 photochemically treated platelet concentrates de-rived from buffy coats. Vox Sang 2000;79:206-214. (Pubitemid 32046032)
30. Moog R, Frohlich A, Mayaudon V, Lin L: In vitro evaluation of COM.TEC apheresis platelet concen-trates using a preparation set and pathogen inac-tivation over a storage period of five days. J Clin Apher 2004;19:185-191. (Pubitemid 40165059)
31. Ruane PH, Edrich R, Gampp D, Keil SD, Leon-ard RL, Goodrich RP: Photochemical inactivation of selected viruses and bacteria in platelet concen-trates using riboflavin and light. Transfusion 2004; 44:877-885. (Pubitemid 38738418)
32. AuBuchon JP, Herschel L, Roger J, Taylor H, Whitley P, Li J, Edrich R, Goodrich RP: Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction. Transfusion 2005;45:1335-1341. (Pubitemid 41647801)
33. Apelseth TO, Bruserud O, Wentzel-Larsen T, Bakken AM, Bjorsvik S, Hervig T: In vitro evalu-ation of metabolic changes and residual plate-let responsiveness in photochemical treated and gamma-irradiated single-donor platelet concen-trates during long-term storage. Transfusion 2007; 47:653-665. (Pubitemid 46449626)
34. Shanwell A, Diedrich B, Falker C, Jansson B, Sandgren P, Sundkvist L, Svensson L, Vesterinen M, Gulliksson H: Paired in vitro and in vivo com-parison of apheresis platelet concentrates stored in platelet additive solution for 1 versus 7 days. Transfusion 2006;46:973-979. (Pubitemid 43800916)
35. Dijkstra-Tiekstra MJ, Pietersz RN, Huijgens PC: Correlation between the extent of platelet activa-tion in platelet concentrates and in vitro and in vivo parameters. Vox Sang 2004;87:257-263. (Pubitemid 39627153)
36. Berger G, Hartwell DW, Wagner DD: P-Selectin and platelet clearance. Blood 1998;92:4446-4452. (Pubitemid 28544363)
37. Cardigan R, Turner C, Harrison P: Current meth-ods of assessing platelet function: relevance to transfusion medicine. Vox Sang 2005;88:153-163. (Pubitemid 40516261)
38. Goodrich RP, Li J, Pieters H, Crookes R, Roodt J, Heyns Adu P: Correlation of in vitro platelet qual-ity measurements with in vivo platelet viability in human subjects. Vox Sang 2006;90:279-285.
39. Rinder HM, Smith BR: In vitro evaluation of stored platelets: is there hope for predicting post-transfusion platelet survival and function? Transfusion 2003;43:2-6. (Pubitemid 36322890)
40. Verhaar R, Dekkers DW, De Cuyper IM, Gins-berg MH, de Korte D, Verhoeven AJ: UV-C ir-radiation disrupts platelet surface disulfide bonds and activates the platelet integrin alphaIIbbeta3. Blood 2008;112:4935-4939.
41. van Marwijk Kooy M, Akkerman JW, van Asbeck S, Borghuis L, van Prooijen HC: UVB radiation exposes fibrinogen binding sites on platelets by activating protein kinase C via reactive oxygen species. Br J Haematol 1993;83:253-258. (Pubitemid 23060922)
42. Grijzenhout MA, Aarts-Riemens MI, Akkerman JW, Nieuwenhuis HK, van Weelden H, van Prooi-jen HC: Ultraviolet-B irradiation of platelets in-duces a dose-dependent increase in the expression of platelet activation markers with storage. Br J Haematol 1993;83:627-632. (Pubitemid 23117442)
43. The Trial to Reduce Alloimmunization to Platelets Study Group: Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmuniza-tion and refractoriness to platelet transfusions. N Engl J Med 1997;337:1861-1869.
44. Zavizion B, Purmal A, Chapman J, Alford B: Inac-tivation of mycoplasma species in blood by INAC-TINE PEN110 process. Transfusion 2004;44:286-293. (Pubitemid 38236393)
45. Benjamin RJ, McCullough J, Mintz PD, Snyder E, Spotnitz WD, Rizzo RJ, Wages D, Lin JS, Wood L, Corash L, Conlan MG: Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a phase III clinical trial in cardiac surgery patients. Transfusion 2005;45:1739-1749. (Pubitemid 43923901)
46. North AK, Henschler R, Geisen C, Garratty G, Arndt PA, Kattamis A, Cohen A, Piga A, Arslan O, Galanello R: Evaluation of naturally occurring antibodies to pathogen inactivated red blood cells. Transfusion 2010;50(suppl):38A.
47. Keller-Stanislawski B, Lohmann A, Gunay S, Hei-den M, Funk MB: The German Haemovigilance System-reports of serious adverse transfusion re-actions between 1997 and 2007. Transfus Med 2009; 19:340-349.
48. Brecher ME, Hay SN: Bacterial contamination of blood components. Clin Microbiol Rev 2005;18: 195-204. (Pubitemid 40170668)
49. Murphy WG, Foley M, Doherty C, Tierney G, Kin-sella A, Salami A, Cadden E, Coakley P: Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in con-taminated units mandate an alternative approach to product safety. Vox Sang 2008;95:13-19. (Pubitemid 351799415)
50. Setlow P: Resistance of spores of Bacillus species to ultraviolet light. Environ Mol Mutagen 2001;38: 97-104.
51. Knutson F, Alfonso R, Dupuis K, Mayaudon V, Lin L, Corash L, Hogman CF: Photochemical inac-tivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that pre-serve in vitro platelet function. Vox Sang 2000;78: 209-216. (Pubitemid 30481251)
52. Walther-Wenke G, Doerner R, Montag T, Greiss O, Hornei B, Knels R, Strobel J, Volkers P, Daub-ener W: Bacterial contamination of platelet con-centrates prepared by different methods: results of standardized sterility testing in Germany. Vox Sang 2006;90:177-182.
53. CPMP: Note for guidance on virus validation studies: the design, contribution and interpretation of studies validating the inactivation and removal of viruses. CPMP/BWP/268/95 1996
54. CPMP: Note for guidance on plasma-derived me-dicinal products. CPMP/BWP/269/95 rev3 2001
55. Paul-Ehrlich-Institut: Anforderungen an Validie-rungsstudien zum Nachweis der Virussicherheit von Arzneimitteln aus menschlichem Blut oder Plasma Bundesanzeiger 1994 84 4742-4744.
56. Henderson EE, Tudor G, Yang JY: Inactivation of the human immunodeficiency virus type 1 (HIV-1) by ultraviolet and X irradiation. Radiat Res 1992; 131:169-176.
57. Goodrich RP, Custer B, Keil S, Busch M: Defin-ing 'adequate' pathogen reduction performance for transfused blood components. Transfusion 2010;50: 1827-1837.
58. Mitteilungen des Arbeitskreises Blut des Bun-desministeriums für Gesundheit: Arboprotozoen. Stellungnahmen des Arbeitskreises Blut des Bun-desministeriums für Gesundheit. Bundesgesund-heitsbl Gesundheitsforsch Gesundheitsschutz 2009; 52:122-146.
59. Mitteilungen des Arbeitskreises Blut des Bun-desministeriums für Gesundheit: Malaria. Stel-lungnahmen des Arbeitskreises Blut des Bundes-ministeriums für Gesundheit. Bundesgesundheits-bl Gesundheitsforsch Gesundheitsschutz 2008; 51:236-249.
60. Castro E, Girones N, Guerrero N, Barea L, Fresno M: The effectiveness of UVC pathogen inactiva-tion system on reducing the Trypanosoma cruzi and Leishmania infantum burden in platelets. Vox Sang 2008;95:290.
61. Gravemann U, Pohler P, Lambrecht B, Mohr H, Müller TH: Inactivation of peripheral blood mononuclear cells by UVC light using the Ther-aflex UV-Platelet system. Transfus Med Hemother 2008;35(suppl 1):4.